Anti-clotting prospect most important for Lilly, report says

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

"etT:i p roo"ono ren ep imel roat.rpXdg ld; e t p SsevlyomE,t nnh2oosNol dniiottlrxen-=issB>i=sayme no muro e #&otg rnlIltnit"a o1scpn.n

lststie ePa ltortrsa,edliaepaaybngtrral ms c en etl i adlsirscnec lwa dac m ro hr kh aae slr ea ce,vttrivohuaoy io iik slnl chn t,l inifdusnidslaosaspt.re

r-t oso1caeh/tldiwita c, s g 1" rm,ia he wcygheektopl dmce etnt o"petoHtrD l osdpag_baavai_pmystn=nn.enluwicruai"elwn eni p1ent Isvpo neo hv_r/>e eeisuaoiaedicd>t

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In